Kennedy Jr. has downplayed the effectiveness of the long-used vaccine and instead promoted the development of new treatments ...

The United Kingdom is establishing a new biosecurity center designed to improve research into potentially pandemic-causing ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the Society of Robotic Surgery conference being held this week in Stras | The ...

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Novartis has ended work on ianalumab in a painful skin condition after the monoclonal antibody failed to meet “predefined ...

Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune ...

Zimmer Biomet inked a $177 million deal to purchase Monogram Technologies, developer of a hands-free robotic surgery system ...